AIM ImmunoTech to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
Live webcast fireside chat on Wednesday, June 21st at 12:00 PM ET OCALA, Fla., June…
Live webcast fireside chat on Wednesday, June 21st at 12:00 PM ET OCALA, Fla., June…
Live webcast fireside chat on Wednesday, June 21st at 12:00 PM ET OCALA, Fla., June…
Live webcast fireside chat on Thursday, June 22nd at 11:30 AM ET Carlsbad, CA, June 14,…
Live webcast fireside chat on Thursday, June 22nd at 11:30 AM ET Carlsbad, CA, June 14,…
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting and General Meeting…
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting and General Meeting…
Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic…
Sath Shukla, current Spero Chief Financial Officer, will bring more than 20 years of strategic…
Pure-Vu system featured in live case during an underwater large polyp resection in the colon…
Pure-Vu system featured in live case during an underwater large polyp resection in the colon…
ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic…
YAVNE, Israel, June 14, 2023 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical…
YAVNE, Israel, June 14, 2023 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical…
DUBLIN, Ireland, June 14, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
DUBLIN, Ireland, June 14, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
DOYLESTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the…
DOYLESTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the…
225 patients now randomized in global Phase 3 clinical trial for IO102-IO103, in combination with…
225 patients now randomized in global Phase 3 clinical trial for IO102-IO103, in combination with…